Funding for this research was provided by:
Royal College of Surgeons in Ireland
Article History
Received: 19 February 2021
Accepted: 21 April 2021
First Online: 30 May 2021
Declarations
:
: JSO’D has served on the speaker’s bureau for Baxter, Bayer, Novo Nordisk, Sobi, Boehringer Ingelheim, Leo Pharma, Takeda, and Octapharma. He has also served on the advisory boards of Baxter, Sobi, Bayer, Octapharma CSL Behring, Daiichi Sankyo, Boehringer Ingelheim, Takeda, and Pfizer. He has also received research grant funding awards from 3 M, Baxter, Bayer, Pfizer, Shire, Takeda, 3 M and Novo Nordisk. FP received honoraria for participating as a speaker at educational meetings, symposia and advisory boards of Roche—Sobi—Sanofi—Grifols – Takeda.